Capricor Therapeutics Inc (CAPR)
EBITDA Margin
0.00%
Quarterly · Period ending:
CAPR EBITDA Margin
Latest reported0.00%period ending
Latest reported0.00%period ending
CAPR Quarterly EBITDA Margin (0.00% → 0.00%)
Quarterly ebitda margin
High-resolution chart · PNG
CAPR ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -60.5624% | |
| -539.2348% | |
| -267.9847% | |
| -192.845% | |
| -3.7597% | |
| -98.8413% | |
| -181.5427% | |
| -252.3914% | |
| -784.3824% | |
| -391.6952% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -2,301.0706% | |
| -12,521.9301% | |
| -7,156.2563% | |
| -22,996.3648% | |
| -6,929.2616% | |
| -1,117.1843% | |
| -648.6529% | |
| -1,115.6394% | |
| -492.9902% | |
| -1,090.6535% | |
| -496.3878% | |
| -1,884.1591% | |
| -1,020.8932% | |
| -912.8494% | |
| 0% | |
| -828.0371% | |
| -334.082% | |
| -399.9737% | |
| -640.8901% | |
| -761.8546% | |
| -502.2722% | |
| -457.399% | |
| -356.6813% | |
| -309.5041% | |
| -332.983% | |
| -325.3359% | |
| -132.2397% | |
| -141.2668% | |
| -140.9789% | |
| -113.1478% | |
| -0.1861% | |
| -1,884.0884% | |
| -849.7298% | |
| -603.058% | |
| 102.579% | |
| -112.663% | |
| 0% | |
| -393.9059% | |
| -850.6394% | |
| -140.4674% | |
| -253.7572% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -4,569.0148% | |
| -10,424.2537% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -3.8004% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -581,950% | |
| 53.9366% | |
| 0% | |
| 0% |